Singapore will read the genomes of 450,000 residents to bring precision medicine into everyday care

Singapore is extending whole-genome sequencing to about 450,000 residents — roughly one in ten people — in Phase III of its National Precision Medicine programme, building on the 100,000 genomes already read under earlier phases. Illumina was selected through an open tender to support the expansion. The goal is practical: spotting disease risk earlier and tailoring treatment to each person's biology as part of ordinary healthcare, not just research.

SDG 3 · Good health and well-being — Mechanism: institutional program